Compare Goldman Sachs Group Inc (GS) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Goldman Sachs Group Inc vs Health Care Select Sector SPDR Fund — how do they compare? Goldman Sachs Group Inc trades at $1,044.01 (market cap $302.01B), while Health Care Select Sector SPDR Fund trades at $169.21. The key difference: Goldman Sachs Group Inc pays a 1.93% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.
| GS | XLV | |
|---|---|---|
Market Cap | $302.01B | — |
Volume | 2,592,735 | — |
Sector | Financials | — |
52-Week High | $1.15K | $168.44 |
52-Week Low | $715.95 | $133.29 |
Dividend Yield | 1.93% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Goldman Sachs (GS) trades at $1,034.41, showing minimal daily movement with a neutral technical stance. The company demonstrates strong fundamental performance with three consecutive quarterly earnings beats and robust profitability metrics including 31.68% net income margin and 18.34% ROE. Recent developments include securing lead roles in high-profile IPOs including Anthropic and SpaceX, positioning the firm for investment banking growth amid expectations of near-record M&A activity in 2026.
The outlook remains positive with analyst consensus targeting $1,160 representing 12% upside potential. Key opportunities include the upcoming IPO wave and strong investment banking pipeline, while risks involve volatile cash flow patterns and market sensitivity to economic conditions. The stock presents a compelling value proposition with a reasonable P/E of 15.97 amid strong earnings momentum.
XLV, the Health Care Select Sector SPDR ETF, trades at $168.44 with a neutral daily change. Technical indicators show a bullish trend from moving averages but oscillators are neutral, with the 6-day RSI at 86.78 suggesting overbought conditions. The fund's low 0.08% expense ratio and defensive healthcare sector exposure attract steady inflows amid market volatility, as highlighted by recent ETF flow reports.
The outlook for XLV is cautiously optimistic, supported by defensive demand and strong sector earnings. Key opportunities include diversification benefits and cost efficiency, while risks involve sector-specific regulatory pressures and broader economic sensitivity. Investors should weigh the ETF's stability against potential growth limitations in a concentrated portfolio.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Goldman Sachs Group Inc
The Goldman Sachs Group, Inc., a bank holding company, is a global investment banking and securities firm specializing in investment banking, trading and principal investments, asset management and securities services. The Company provides services to corporations, financial institutions, governments, and high-net worth individuals.
Read more on GS →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
